NCT01586117 A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity Status UNKNOWN Phase PHASE2
NCT01582750 Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy Status UNKNOWN Phase N/A
NCT01579721 Prospective Randomized Study of SILS Versus CLS for Rectal Cancer Status COMPLETED Phase PHASE4
NCT01579591 VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer Status UNKNOWN Phase PHASE3
NCT01560377 Perfusion Assessment in Laparoscopic Left Anterior Resection Status COMPLETED Phase PHASE1
NCT01558921 Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01554969 Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer Status COMPLETED Phase PHASE1
NCT01552226 Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery Status COMPLETED Phase NA
NCT01544452 Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Cancer Status TERMINATED Phase NA
NCT01525056 Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI Status COMPLETED Phase PHASE2
NCT01511653 Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma Status COMPLETED Phase N/A
NCT01500993 Capecitabine in the Perioperative Treatment of Rectal Cancer Status COMPLETED Phase PHASE3
NCT01489332 Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer Status UNKNOWN Phase PHASE2
NCT01481545 Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer Status COMPLETED Phase PHASE2
NCT01477229 Quality of Life in RECTal Cancer - a Prospective Multicenter Cohort Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01474187 Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer Status UNKNOWN Phase PHASE1